Ryosuke Miura

Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial

Nao Matsuyama, Shinobu Shimizu, Kazuto Ueda et al. · BMJ Open · 2022 · 20 citations · Full text

Medicine, Pediatrics, Pharmacology +14

Altered offspring neurodevelopment in an L-NAME-induced preeclampsia rat model

Noriyuki Nakamura, Takafumi Ushida, Atsuto Onoda et al. · Frontiers in Pediatrics · 2023 · 20 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Fetal growth restriction followed by early catch-up growth impairs pancreatic islet morphology in male rats

Mahboba Jabary, Atsuto Onoda, Yuma Kitase et al. · Scientific Reports · 2023 · 14 citations · Full text

Medicine, Endocrinology, Physiology +17

Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial)

Yoshiaki Sato, Shinobu Shimizu, Kazuto Ueda et al. · Stem Cells Translational Medicine · 2024 · 13 citations · Full text

Medicine, Pharmacology, Cell Therapy +14

Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic–ischemic brain injury in neonatal rats

Kazuto Ueda, Yoshiaki Sato, Shinobu Shimizu et al. · Scientific Reports · 2023 · 10 citations · Full text

Medicine, Neuroscience, Pharmacology +17